Searched for
ALKEM LABORATORIES SALE
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...- Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani PortsMarkets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,...
- Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyersAlkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Alkem Laboratories to sell Pithampur unit for Rs 149 croreAlkem Laboratories Ltd agrees to sell its manufacturing facility in Pithampur, Madhya Pradesh, to Rubicon Research Ltd for Rs 149 crore via...
- Buy Alkem Laboratories, target price Rs 3730: Motilal OswalAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 37548.79 Crore) operating in Phar...
- Buy Alkem Laboratories, target price Rs 3430: Motilal OswalAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 34831.08 Crore) operating in Phar...
- Buy Alkem Laboratories, target price Rs 3570: Motilal OswalAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 32876.79 Crore) operating in Phar...
- Alkem Laboratories Q2 results: Net profit up 27% to Rs 482 crConsolidated revenue from operations of the company stood at Rs 2,362.80 crore for the quarter under consideration. It was Rs 2,264.03 cror...
- Buy Alkem Laboratories, target price Rs 3665: Motilal OswalAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 33677.87 Crore) operating in Phar...
- Buy Alkem Laboratories, target price Rs 3679: ICICI SecuritiesAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 34590.75 Crore) operating in Phar...
- Alkem Labs Q1 results: Net profit jumps over 2-fold to Rs 423.19 croreThe company had posted a net profit of Rs 187.29 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a BS...
- Buy Alkem Labs, target price Rs 2902: ICICI SecuritiesAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 29903.21 Crore) operating in Phar...
- Buy Alkem Laboratories, target price Rs 3,300: Angel BrokingThe company is expected to outperform the Indian Pharmaceutical market (IPM) by 1.5 times growth rate for the next two years.
- Buy Alkem Laboratories, target price Rs 2,700: Motilal OswalThe evolving situation due to the Covid-19 outbreak is likely to have a mixed impact on the domestic formulation (DF) growth outlook over t...
- Alkem Laboratories Q1 net profit jumps 36% to Rs 187.29 croreCompany's India sales grew by 12.1% YOY, recording sales of Rs 1,222 cr.
- Buy Alkem Laboratories, target Rs 2,340: HDFC SecuritiesBuy Alkem Laboratories at a price target of Rs 2,340.
- Alkem Laboratories Q4 net up 58% at Rs 136.96 croreThe company had posted a net profit of Rs 86.54 crore in the same period of the previous fiscal
- Alkem recalls three lakh injections from abroadAlkem alleges that Synergia and Centre Specialities Export Pharma were trying to malign the company after it decided to tap France & Africa...
Load More
